Nuvalent, Inc.
Biotechnology Research
Cambridge, Massachusetts, United States
208 employees
- Employees
- 208
- Contacts
- 2
- Emails
- 2
- Phones
- 1
Nuvalent, Inc. Overview
- Headquarters
- Cambridge, Massachusetts, United States
- Website
- www.nuvalent.com
- Industry
- Biotechnology Research
- Employees
- 208
- Founded
- 2017
- Funding
- 575.0M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Nuvalent, Inc.
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs. To learn more, visit www.nuvalent.com.
Nuvalent, Inc. Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Nuvalent, Inc. Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Bill Pentz | West Chester, Pennsylvania, United States |
Email
|
|
| Kimia Keshtbod, Mba | Saratoga, California, United States |
View
|
|
| Denise Goluboff | Greater Boston, United States |
Email
Phone
|
|
| Adelicia Brabant, PMP | C-suite Executive Assistant - Strategic | Greater Boston, United States |
View
|
Compare Similar Companies to Nuvalent, Inc.
Tessera Therapeutics
Biotechnology Research
KalVista Pharmaceuticals, Inc.
Biotechnology Research
Dyno Therapeutics
Biotechnology Research
Rapport Therapeutics
Biotechnology Research
Bicara Therapeutics
Biotechnology Research
GC Therapeutics
Biotechnology Research
Quiver Bioscience
Biotechnology Research
Fable Therapeutics
Biotechnology Research
Delphia Therapeutics
Biotechnology Research
Myrobalan Therapeutics
Biotechnology Research